4-benzyl-3-crotonyl-2-oxazolidinone and B-Cell Chronic Lymphocytic Leukemia

4-benzyl-3-crotonyl-2-oxazolidinone has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Best, OG; Christopherson, RI; Crassini, K; Mulligan, SP; Pyke, T; Shen, Y; Stevenson, WS	1

Other Studies

1 other study(ies) available for 4-benzyl-3-crotonyl-2-oxazolidinone and B-Cell Chronic Lymphocytic Leukemia

Article	Year
Inhibition of the Raf-1 kinase inhibitory protein (RKIP) by locostatin induces cell death and reduces the CXCR4-mediated migration of chronic lymphocytic leukemia cells. Leukemia & lymphoma, 2018, Volume: 59, Issue:12 Topics: Apoptosis; Cell Line, Tumor; Cell Movement; Cell Survival; Down-Regulation; Drug Screening Assays, Antitumor; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocytes, Mononuclear; MAP Kinase Signaling System; Oxazolidinones; Phosphatidylethanolamine Binding Protein; Phosphorylation; Primary Cell Culture; Receptors, CXCR4	2018

Article

Year

Inhibition of the Raf-1 kinase inhibitory protein (RKIP) by locostatin induces cell death and reduces the CXCR4-mediated migration of chronic lymphocytic leukemia cells.

Leukemia & lymphoma, 2018, Volume: 59, Issue:12

Topics: Apoptosis; Cell Line, Tumor; Cell Movement; Cell Survival; Down-Regulation; Drug Screening Assays, Antitumor; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocytes, Mononuclear; MAP Kinase Signaling System; Oxazolidinones; Phosphatidylethanolamine Binding Protein; Phosphorylation; Primary Cell Culture; Receptors, CXCR4

2018